GSK_Annual_Report_2021

Notes to the Consolidated Financial Statements for the year ended March 31, 2021 (contd.) Financial Statements GlaxoSmithKline Pharmaceuticals Limited 214 Exposure to liquidity risk The following are the remaining contractual maturities of financial liabilities at the reporting date. The amounts are gross and undiscounted, and include estimated interest payments and exclude the impact of netting agreements. ( ` in lakhs) As at March 31, 2021 Carrying amount Contractual cash flows Total 1 year or less 1-2 years 2-5 years More than 5 years Non-derivative financial liabilities Borrowings 2.40 2.40 2.40 - - - Trade Payables and other payables 616,49.19 616,49.19 616,49.19 - - - Unclaimed dividends 19,86.36 19,86.36 19,86.36 - - - Security deposits received 2,05.09 2,05.09 - - 2,05.09 - Refer note 46 for remaining contractual maturities of financial lease liabilities at the reporting date. ( ` in lakhs) As at March 31, 2020 Carrying amount Contractual cash flows Total 1 year or less 1-2 years 2-5 years More than 5 years Non-derivative financial liabilities Borrowings 17.70 17.70 15.30 2.40 - - Trade Payables and other payables 479,36.72 479,36.72 479,36.00 - 0.72 - Unclaimed dividends 20,44.34 20,44.34 20,44.34 - - - Security deposits received 2,06.60 2,06.60 - - 2,06.60 - Market risk Market risk is the risk of loss of future earnings, fair values or future cash flows that may result from adverse changes in market rates and prices (such as interest rates and foreign currency exchange rates) or in the price of market risk- sensitive instruments as a result of such adverse changes in market rates and prices. Market risk is attributable to all market risk-sensitive financial instruments, all foreign currency receivables and payables. The Group is exposed to market risk primarily related to foreign exchange rate risk. Currency risk The fluctuation in foreign currency exchange rates may have potential impact on the statement of profit and loss, where any transaction references more than one currency or where assets/liabilities are denominated in a currency other than the functional currency of the entity. The Group is exposed to currency risk on account of its receivables and payables in foreign currency. The functional currency of the Group is Indian Rupee. The Group has exposure to GBP, USD, EUR and other currencies. The Group has not hedged this foreign currency exposure and strives to achieve asset liability offset of foreign currency exposure.